Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gina Mejía-Abril (Gina Mejía)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Pharmaceutics

Journal of personalized medicine

Human psychopharmacology

Biomedicines

Hospital Universitario de La Princesa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario de La Princesa Sep 1o 2015

Spain

Médica especialista en Farmacología Clínica :: Farmacología Clínica

Publications

Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Marcos Navares-Gómez, Houwaida Abbes, Gonzalo Villapalos-García, Alejandro de Miguel, Eva González-Iglesias, Andrea Rodríguez-Lopez, Gina Mejía-Abril, Samuel Martín-Vilchez, Sergio Luquero-Bueno, Manuel Román, Francisco Abad-Santos
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International journal of molecular sciences 24 (20) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Gonzalo Villapalos-García, Pablo Zubiaur, Cristina Marián-Revilla, Paula Soria-Chacartegui, Marcos Navares-Gómez, Gina Mejía-Abril, Andrea Rodríguez-Lopez, Eva González-Iglesias, Samuel Martín-Vílchez, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. Journal of personalized medicine 13 (11) (2023)
Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui, Ana Casajús, Gonzalo Villapalos-García, Marcos Navares-Gómez, Antía Gómez-Fernández, Raúl Parra-Garcés, Gina Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 15 (11) (2022)
Pablo Zubiaur, David Nicolás Prósper-Cuesta, Jesús Novalbos, Gina Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Francisco Abad-Santos
Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review. Journal of personalized medicine 12 (2) (2022)
Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics 14 (10) (2022)
Pablo Zubiaur, Gina Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Miriam Saiz-Rodríguez, Dolores Ochoa, Francisco Abad-Santos
PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics. Journal of clinical medicine 10 (17) (2021)
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández, Marcos Navares-Gómez, Gina Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study. Pharmaceutics 13 (12) (2021)
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 13 (10) (2021)
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, Gina Mejía-Abril, Miriam Saiz-Rodríguez, Alberto M Borobia, Dora Koller, Irene García García, Marcos Navares-Gómez, Georg Hempel, Francisco Abad-Santos
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 60 (2) (2021)
Dora Koller, Susana Almenara, Gina Mejía-Abril, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 36 (1) (2020)
Miriam Saiz-Rodríguez, Susana Almenara, Marcos Navares-Gómez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, María Santos, Gina Mejía-Abril, Alberto M Borobia, Cristina Rodríguez-Antona, Francisco Abad-Santos
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines 8 (4) (2020)

Gina Mejía-Abril.css-eqlu8i{font-size:small;padding-left:4px;} (Gina Mejía)

Publication Activity (10 Years)

Top Topics

Top Venues

Gina Mejía-Abril (Gina Mejía)